A False Claims Act lawsuit is a civil claim filed against a person or company that has defrauded the federal government by submitting false bills, making false statements, or concealing information to receive government money unlawfully. The False Claims Act (31 U.S.C. § 3729) is one of the most powerful tools the government uses to recover money lost to fraud in major programs like Medicare, defense contracting, and federal grants. When a company overbills Medicare by tens of thousands of dollars, a defense contractor uses substandard materials on a government project, or a pharmaceutical company misrepresents dosing information to the FDA, a False Claims Act case can be the legal mechanism that exposes and punishes that fraud. The stakes are enormous. In fiscal year 2025, the Department of Justice recovered $6.8 billion through False Claims Act settlements and judgments—the largest annual total in the statute’s history.
A single settlement can reach into the hundreds of millions. For example, Kaiser Permanente paid $556 million in FY 2025 to resolve allegations that it submitted unsupported diagnosis codes for Medicare Advantage beneficiaries, artificially inflating reimbursements. These aren’t small disputes—they’re cases that reshape how entire industries operate. What makes False Claims Act cases particularly significant is that they can be filed not only by the government but also by private citizens called “relators” or whistleblowers under a mechanism called qui tam. Since 1987, whistleblowers have received nearly $10 billion in awards by exposing fraud, and their cases have driven record enforcement activity. In FY 2025, 1,297 qui tam cases were filed—a record and a 32% increase from the prior year—meaning more insiders than ever are stepping forward with evidence of corporate fraud.
Table of Contents
- What Is a False Claims Act Lawsuit and How Does It Work?
- Healthcare and Government Contracting: Where False Claims Act Cases Are Won and Lost
- The Qui Tam Whistleblower Advantage in False Claims Act Cases
- Filing a False Claims Act Claim: Process, Costs, and Strategic Considerations
- Expanding Enforcement Theories and Emerging False Claims Act Litigation Trends
- Record Recoveries and Cumulative Impact on Federal Enforcement
- The Future of False Claims Act Litigation and What Companies Should Expect
- Conclusion
What Is a False Claims Act Lawsuit and How Does It Work?
A False Claims act lawsuit holds companies accountable for knowingly submitting false claims for federal money. The law defines a “claim” broadly to include billing documents, invoices, applications for grants, and even certifications or statements made to secure federal funds. The key legal question is whether the defendant acted “knowingly”—this includes actual knowledge, deliberate ignorance of the truth, or reckless disregard for whether a statement is true. The defendant doesn’t have to intend to defraud the government; gross negligence or willful blindness can be enough. The damages under the False Claims Act are treble damages—three times the government’s actual losses—plus civil penalties of up to $11,000 per false claim (adjusted for inflation). This means a company that submits 10,000 false Medicare claims could owe three times the amount overbilled plus $110 million in penalties.
This formula explains why False Claims Act recoveries dwarf most other civil litigation settlements. Perfectus Aluminum, for instance, agreed to pay $549.5 million to resolve allegations of customs duty evasion, with a whistleblower who exposed the fraud receiving a $96.1 million award (17.5% of recovery). Qui tam lawsuits are filed by private relators who have knowledge of fraud and serve as representatives for the government. The relator files the complaint under seal, and the Department of Justice has 60 days to decide whether to intervene and take over the case. If the government joins the lawsuit, it controls the litigation and leads settlement negotiations. If the government declines to intervene, the relator can proceed alone—though at greater financial and legal risk. Relators who succeed typically receive 15-30% of the recovery, creating a powerful financial incentive for employees or contractors to report fraud they witness.
Healthcare and Government Contracting: Where False Claims Act Cases Are Won and Lost
Healthcare is the dominant enforcement arena, accounting for $5.7 billion (84%) of the $6.8 billion recovered in FY 2025. Medicare fraud drives the majority of healthcare cases—coding fraud, unbilled services, unnecessary treatments, kickback schemes, and disability fraud all fall within False Claims Act jurisdiction. In one recent case, a prescription drug company faced a $1.6 billion verdict in a qui tam lawsuit for misrepresenting the safety and efficacy of its medications to government healthcare programs. Another drug pricing conspiracy resulted in a $289 million verdict. These verdicts show that even when the government doesn’t intervene, relators and their attorneys can win enormous judgments by proving false claims to Medicare and Medicaid. Government contractors also face intense False Claims Act scrutiny. Companies receiving federal defense, infrastructure, or research contracts must comply with specific requirements—using union labor, sourcing domestic materials, meeting quality standards.
When a contractor cuts corners, falsifies test results, or misrepresents its compliance, the False Claims Act applies. The recent IBM settlement of $17 million in April 2026 marked the first False Claims Act resolution under the DOJ’s new Civil Rights Fraud Initiative, focusing on companies that make false claims regarding diversity and inclusion practices on federal contracts. This signals a broader enforcement direction: the government is expanding False Claims Act theories beyond traditional fraud. A critical limitation to understand is that False Claims Act cases require evidence of actual knowledge or reckless disregard—negligence alone isn’t enough. A healthcare provider that makes honest mistakes in coding, or a contractor that fails to meet a technical specification due to inadvertent error, may not face False Claims Act liability. The line between negligence and fraud is where many False Claims Act defenses are built. Additionally, companies can invoke “implied certification” defenses, arguing that even if a claim didn’t explicitly certify compliance, the government couldn’t prove it relied on certification as a condition of payment.
The Qui Tam Whistleblower Advantage in False Claims Act Cases
Qui tam provisions are what fuel False Claims Act enforcement, especially in cases the government wouldn’t otherwise pursue. A qui tam case allows an insider—a former employee, contractor, subcontractor, or competitor with direct knowledge—to file a confidential lawsuit on behalf of the United States. The relator doesn’t need permission from the government to file; the government simply gets an opportunity to decide whether to take the case. In FY 2025, 1,297 qui tam cases were filed, representing an all-time high and a 32% increase from the prior year’s 980 cases. This surge reflects both growing whistleblower activity and companies’ increasing willingness to report suspected fraud. When a qui tam relator succeeds, the rewards are substantial. The relator receives 15-30% of any recovery—money that goes directly to the person who had the courage to report fraud, often at personal and professional cost.
Whistleblowers have collectively received nearly $10 billion in awards since 1987. The Perfectus Aluminum case illustrates this: a whistleblower involved in the customs evasion scheme reported it and received a $96.1 million share of the $549.5 million settlement. These awards are designed not only to compensate relators for their courage but also to incentivize employees throughout industry to report fraud rather than ignore it. Qui tam cases can also proceed to trial and verdict without government intervention. In recent years, several non-intervened qui tam cases have resulted in multibillion-dollar verdicts. The $1.6 billion prescription drug verdict and $289 million generic drug pricing verdict demonstrate that relators and their attorneys can win massive judgments through litigation. However, this route is more expensive and risky for relators, who must fund their own litigation. Many qui tam attorneys work on contingency and carefully evaluate cases before investing in years of litigation.
Filing a False Claims Act Claim: Process, Costs, and Strategic Considerations
If you have knowledge of a company defrauding the government, the first step is typically to consult with a False Claims Act attorney. These cases are highly technical—involving regulatory compliance, government procurement rules, and complex damages calculations—and mistakes in pleading can be fatal. An attorney experienced in qui tam litigation will evaluate your knowledge, assess the strength of the potential claim, and discuss the financial risks and rewards. Some False Claims Act attorneys work entirely on contingency, meaning they advance litigation costs and take a percentage of recovery. This arrangement means a relator with limited financial resources can still pursue a valid claim. The formal process begins with filing a complaint under seal in federal court, which means the case remains confidential while the Department of Justice investigates and decides whether to intervene. This seal protection is critical—it prevents the defendant from learning of the whistleblower’s identity while the government evaluates the case.
If the government intervenes, it takes control of settlement discussions and litigation strategy. If it declines, the relator can still proceed, but at higher risk and potentially without the credibility that government backing provides. The Department of Justice’s decision to intervene signals to the defendant that prosecutors believe the case has merit, which often influences settlement negotiations. One important tradeoff in qui tam litigation is the balance between speed and certainty. A relator might settle early and receive a guaranteed payment (15-30% of a negotiated recovery), or pursue litigation to trial in hopes of winning a larger verdict. The prescription drug and generic drug cases that won $1.6 billion and $289 million respectively took years of litigation to resolve, and success wasn’t guaranteed. Early settlements, by contrast, provide certainty but may leave money on the table. An experienced False Claims Act attorney helps relators weigh these strategic considerations based on the strength of the evidence, the defendant’s financial condition, and the relator’s personal circumstances.
Expanding Enforcement Theories and Emerging False Claims Act Litigation Trends
The Department of Justice is significantly expanding False Claims Act enforcement beyond traditional billing fraud. In January 2026, the DOJ created a new Division for National Fraud Enforcement, signaling that False Claims Act cases are a top-tier enforcement priority. The IBM settlement in April 2026 exemplifies this expansion—the government pursued False Claims Act claims based on alleged fraud in diversity and inclusion certifications on federal contracts. This suggests that defendants can’t assume False Claims Act liability only applies to billing, pricing, or product quality fraud; certifications regarding labor practices, environmental compliance, and other policy areas may also expose companies to suit. Healthcare and government contracting remain the core enforcement areas, with these sectors serving as the focus of aggressive 2026 enforcement efforts. The DOJ has concentrated resources on healthcare providers and government contractors, viewing them as the greatest sources of fraud.
However, the expansion into civil rights fraud (the IBM case) indicates the government’s willingness to pursue broader theories of false claims. A company that certifies compliance with federal policies—whether regarding diversity, environmental standards, labor practices, or other regulatory requirements—may face False Claims Act liability if that certification is untrue. One significant limitation practitioners emphasize is the difficulty of proving scienter (knowledge of falsity) in cases involving complex regulatory compliance. A healthcare provider might genuinely dispute whether a coding decision was correct, making it harder to prove “knowing” submission of a false claim. Similarly, a contractor might argue that a failure to meet specifications resulted from interpretation differences, not intentional fraud. These defenses succeed regularly, meaning not all suspected fraud translates into viable False Claims Act cases. Relators and their attorneys must carefully assess whether the evidence supports a knowing or reckless disregard theory before committing to litigation.
Record Recoveries and Cumulative Impact on Federal Enforcement
The False Claims Act’s impact on federal enforcement has been extraordinary. Since 1986, cumulative recoveries have exceeded $85 billion, with FY 2025 setting a new record at $6.8 billion. To put this in perspective, the False Claims Act generates more federal revenue recovery than most civil enforcement mechanisms. The statute’s reliance on private relators and contingency-fee attorneys has created a parallel enforcement system that augments limited government resources.
The scale of recent settlements demonstrates why False Claims Act cases matter. Kaiser Permanente’s $556 million settlement, Perfectus Aluminum’s $549.5 million resolution, and the $1.6 billion prescription drug verdict represent extraordinary recoveries that wouldn’t be possible under standard civil litigation frameworks. These cases return substantial federal funds to Medicare, Medicaid, and defense budgets—money that pays for patient care, military readiness, and infrastructure. For relators, they represent life-changing awards: a whistleblower receiving 20% of a $500 million settlement has earned $100 million for having the integrity to report fraud.
The Future of False Claims Act Litigation and What Companies Should Expect
The trajectory is clear: False Claims Act enforcement will intensify. The FY 2025 numbers—1,698 new cases filed, 1,297 qui tam cases (a 32% increase), $6.8 billion in recoveries—represent an enforcement environment companies must take seriously. With the DOJ’s new Division for National Fraud Enforcement, and healthcare and government contractors explicitly in the crosshairs, organizations in these sectors should expect heightened scrutiny. The expansion into civil rights fraud and compliance certifications suggests that the government’s theories of “false claims” will continue to broaden.
For whistleblowers, the environment is increasingly favorable. Qui tam lawsuits have become a proven mechanism for pursuing fraud that companies would otherwise hide. With relator awards nearly reaching $10 billion cumulatively and FY 2025 setting records for both case filings and recoveries, the incentive structure strongly encourages insiders to report fraud. If you have evidence that your employer is defrauding the government—whether through billing, contracting, compliance certifications, or other means—a False Claims Act attorney can evaluate your case confidentially and discuss your options. The law explicitly protects relators from retaliation, giving legal foundation to report wrongdoing.
Conclusion
A False Claims Act lawsuit is a federal civil action designed to hold companies accountable when they defraud the government through false billing, misrepresentations, or concealment of material facts. Whether filed by the government directly or by private whistleblowers under qui tam provisions, these cases have recovered more than $85 billion since 1986 and are accelerating at record rates. The combination of treble damages, civil penalties, and relator rewards creates a powerful deterrent against fraud and an incentive structure that encourages employees to report wrongdoing.
Understanding False Claims Act liability is essential for companies in healthcare, government contracting, and other federally funded sectors. For whistleblowers who have witnessed fraud, the False Claims Act offers a legal pathway to report misconduct, receive financial rewards, and help protect taxpayer money. With enforcement activity at historic levels and the DOJ’s commitment to expansion, False Claims Act cases will remain a dominant force in federal civil litigation for years to come.